We are live on ! Find out more
Aviva

Aviva Portfolio holdings

AUM $59.6B
1-Year Est. Return 28.44%
This Fund
S&P 500
This Quarter Est. Return
-12.99%
1 Year Est. Return
+28.44%
3 Year Est. Return
+95.57%
5 Year Est. Return
+123.24%
10 Year Est. Return
+442.53%
AUM
$13.4B
AUM Growth
-$4.83B
Cap. Flow
-$2.41B
Cap. Flow %
-17.99%
Top 10 Hldgs %
17.99%
Holding
766
New
17
Increased
73
Reduced
644
Closed
16

Top Buys

Rank Stock Value
1
FTI icon
TechnipFMC
FTI
+$129M
2
LIN icon
Linde
LIN
+$57.4M
3
RY icon
Royal Bank of Canada
RY
+$32.4M
4
TD icon
Toronto Dominion Bank
TD
+$30.8M
5
CME icon
CME Group
CME
+$27M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$106M
2
MSFT icon
Microsoft
MSFT
+$88.1M
3
SPG icon
Simon Property Group
SPG
+$69.1M
4
AMZN icon
Amazon
AMZN
+$68M
5
ZTS icon
Zoetis
ZTS
+$61M

Sector Composition

Rank Sector Weight
1 Financials 17.01%
2 Technology 15.39%
3 Healthcare 13.83%
4 Industrials 11.32%
5 Consumer Discretionary 9.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGN
101
DELISTED
Allergan plc
AGN
$32.6M 0.24%
243,759
-34,952
-13% -$5.73M
CSX icon
102
CSX Corp
CSX
$93.9B
$32.1M 0.24%
1,548,456
-236,787
-13% -$5.45M
DE icon
103
Deere & Co
DE
$166B
$30.2M 0.23%
202,602
-28,721
-12% -$4.21M
SBUX icon
104
Starbucks
SBUX
$120B
$29.8M 0.22%
462,009
-200,452
-30% -$12.5M
TMUS icon
105
T-Mobile US
TMUS
$193B
$29.7M 0.22%
466,337
-28,433
-6% -$1.91M
NVDA icon
106
NVIDIA
NVDA
$5.3T
$29.3M 0.22%
8,793,480
-2,505,760
-22% -$12M
LOW icon
107
Lowe's Companies
LOW
$122B
$28.5M 0.21%
308,310
-87,701
-22% -$8.46M
UBS icon
108
UBS Group
UBS
$173B
$27.6M 0.21%
2,219,961
-140,153
-6% -$1.9M
EW icon
109
Edwards Lifesciences
EW
$51.5B
$27.2M 0.2%
533,496
-56,988
-10% -$2.88M
CI icon
110
Cigna
CI
$72.7B
$26.6M 0.2%
140,058
+25,679
+22% +$5.36M
ITW icon
111
Illinois Tool Works
ITW
$84.8B
$26.4M 0.2%
208,325
-32,075
-13% -$4.22M
CM icon
112
Canadian Imperial Bank of Commerce
CM
$108B
$26.2M 0.2%
703,094
+274,456
+64% +$11.7M
USB icon
113
US Bancorp
USB
$99.4B
$26.2M 0.2%
573,591
-172,624
-23% -$8.89M
CTSH icon
114
Cognizant
CTSH
$25.6B
$26.1M 0.19%
410,571
-56,973
-12% -$3.96M
QCOM icon
115
Qualcomm
QCOM
$168B
$26M 0.19%
457,635
-280,110
-38% -$17M
NSC icon
116
Norfolk Southern
NSC
$76.9B
$25.9M 0.19%
173,137
-28,572
-14% -$4.7M
ELV icon
117
Elevance Health
ELV
$84.9B
$25.8M 0.19%
98,328
-26,201
-21% -$7.2M
TRP icon
118
TC Energy
TRP
$66.6B
$25.8M 0.19%
720,079
+290,403
+68% +$11.5M
BN icon
119
Brookfield
BN
$108B
$25.7M 0.19%
1,878,708
+732,388
+64% +$10.9M
MU icon
120
Micron Technology
MU
$996B
$25.7M 0.19%
810,176
-124,583
-13% -$4.72M
SLB icon
121
SLB Ltd
SLB
$76.5B
$25.7M 0.19%
711,799
-141,505
-17% -$6.98M
CELG
122
DELISTED
Celgene Corp
CELG
$24.9M 0.19%
389,101
-79,840
-17% -$5.89M
CONE
123
DELISTED
CyrusOne Inc Common Stock
CONE
$24.5M 0.18%
463,482
-59,319
-11% -$3.39M
WM icon
124
Waste Management
WM
$91.5B
$23.8M 0.18%
267,697
-40,839
-13% -$3.67M
AXP icon
125
American Express
AXP
$231B
$23.8M 0.18%
249,394
-82,668
-25% -$8.65M

Similar funds

Aviva's Q4 2018 Portfolio in Review

As of Q4 2018, Aviva held 766 positions worth $13.4B, down 26% from $18.2B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Aviva withdrew a net $2.41B in Q4 2018, closing 16 positions and reducing 644 holdings. Its most notable exit was Praxair Inc, an estimated $45.6M position sold in full.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Aviva opened a new position in Linde worth $56.7M.

  • Aviva's largest Q4 2018 buy was Linde: 363,196 shares worth $56.7M.
  • Aviva added most to TechnipFMC in Q4 2018, an estimated $129M increase.
  • Aviva's biggest Q4 2018 reduction was Apple, cutting an estimated $106M.
  • Aviva fully exited Praxair Inc in Q4 2018, selling an estimated $45.6M.
  • Aviva's ten largest holdings make up 18% of its $13.4B portfolio in Q4 2018.
  • Aviva opened 17 new positions and closed 16 in Q4 2018.
  • Aviva's portfolio value fell 26% quarter-over-quarter to $13.4B.

Based on Aviva's 13F filing for Q4 2018, filed 12 Feb 2019.